Verva Reports Passing of Verva Director Dr. Andrew Rainsford Baker

Melbourne, Australia (23 March, 2012).  Verva Pharmaceuticals Ltd. regretfully reports the recent passing of Verva Director Dr. Andrew Baker after a battle with cancer.  Andrew was 50 years old.  He is survived by his wife Nancy, son Sam and daughter Clare.

Andrew was a Partner at GBS Venture Partners and one of Verva’s founding Directors.  Andrew drew on his extensive international industry experience (including work with industry leaders Genentech, Bayer and Johnson & Johnson) to provide essential guidance and strategic advice in advancing Verva’s corporate and product development programs.

Verva CEO Vince Wacher stated: “We are very saddened by Andrew’s untimely loss and express our heartfelt condolences to his family.”

A Memorial Service for Andrew will be held at St. Leonards Uniting Church, 2 Wolseley Ave, Brighton, Victoria on Monday 26 March 26, 2012 at 1.30 p.m.  In lieu of flowers, donations to the Australasian Sarcoma Study Group would be greatly appreciated.  Please note Andrew Baker as the bequest.

Andrew’s seat on the Verva board will be assumed by Dr. Steve Gourlay, also a Partner at GBS Venture Partners.